FDA inspection
Resilience Biotechnologies, Inc.: FDA inspection ending Nov 10, 2023
FDA inspection 1222580 · Voluntary Action Indicated (VAI) · Mississauga
Key facts
| Inspection ID | 1222580 |
|---|---|
| Firm | Resilience Biotechnologies, Inc. |
| FEI number | 3007503037 |
| Address | 2585 Meadowpine Blvd |
| City | Mississauga |
| Country | Canada |
| Fiscal year | 2024 |
| Inspection end date | Nov 10, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data